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VSA.
It has been well known that the coronary spasm might be closely associated with atherosclerosis. 9 Interestingly, previous reports also suggested that a recurrent coronary spasm had a major role in or at least some relationship with the progression of coronary atherosclerosis in the spasm-positive segments. 9-12 However, the correlation between the coronary spasm and the progression of atherosclerosis is still unclear. Moreover, there have been few reports on the development of significant atherosclerosis that leads to percutaneous coronary intervention (PCI) in patients with known VSA. Consequently, the determination of the rate of PCI due to the development of significant atherosclerosis and the cardiac mortality rate in Korean patients with VSA was planned.
Methods

Subjects
In this retrospective study, the data-sets of the VA-CMC (Vasospastic Angina in the Catholic Medical Center) registry were used to determine the rate of PCI and the cardiac mortality rate in patients with VSA. The VA-CMC is an observational Web-based registry of demographic, clinical, and angiographic data of Korean patients with VSA. The clinical outcome of the patients registered from 8 hospitals affiliated with the Catholic University of Korea between January 2008 and November 2011 were also determined. Patients who had suspicious symptoms, such as resting angina at night or in the early morning, underwent coronary angiography (CAG) with a provocation test of VSA. Of these patients, only those in which coronary spasm was definitely documented via the provocation test were enrolled in the registry.
Of the VSA patients who were registered in the registry, only the patients who showed normal findings or minimal atherosclerotic stenosis (<50% of luminal diameter narrowing) on their baseline CAG were included in this study, whereas the patients who had significant atherosclerotic stenosis (>50% of luminal diameter narrowing) on the baseline CAG were excluded. Thus, subjects in this study were VSA patients without significant atherosclerosis on the baseline CAG. Patients with renal failure (estimated glomerular filtration rate <70 ml/min), known malignant or inflammatory diseases, and catheter-induced spasm in their angiography were also excluded. There was no industry involvement in the design, conduct, and analysis of this study. All the included patients gave their written informed consent to participate in this study, and all the surveys were approved by the institutional review board of each participating institution.
CAG With a Provocation Test for VSA
The VSA diagnosis was made based on the criteria presented in previous studies and the Guidelines for Diagnosis and Treatment of Patients with Vasospastic Angina of the Japanese Circulation Society. 9, 13 After intracoronary (IC) infusion of Figure 1 . The 59-year-old male patient with VSA. In the VSA provocation test, (A) diffuse vasospasm was provoked on the proximal and distal segments of the RCA via IC infusion of 20 μg of ergonovine, and (B) transient total occlusion occurred on the proximal segment of the RCA with the administration of 40 μg of ergonovine. The vasospasm was relieved via (C) an IC injection of nitrates. After 29 months, the follow-up CAG showed (D) the development of significant atherosclerosis on the proximal segment of the RCA, so (E,F) PCI was performed. VSA, vasospastic angina; RCA, right coronary artery; IC, intracoronary; CAG, coronary angiography; PCI, percutaneous coronary intervention. Long-Term Prognosis of Korean VSA Patients normal saline (5 ml), the baseline CAG was performed using trans-femoral or -radial approaches. The provocation test of VSA was performed using phased IC infusion of acetylcholine or ergonovine. For the provocation test with acetylcholine, incremental doses of 25 and 50 micrograms (μg) of acetylcholine were injected into the right coronary artery (RCA), and 25, 50, and 100 μg into the left coronary artery (LCA). For the provocation test with ergonovine, incremental doses of 20 and 40 μg of ergonovine were injected into the RCA, and 20, 40, and 80 μg into the LCA. When a coronary spasm was induced, it was relieved immediately by IC nitrates. The administration of the medications that have known effects on vasomotion, such as CCBs and long-acting nitrates, were stopped at least 48 h before the test. The definition of a positive result in the provocation test was a "total or subtotal (>90% of transient luminal diameter narrowing) coronary artery occlusion during the provocation test, accompanied by chest pain and/or ischemic electrocardiographic (ECG) changes". The degree of vasoconstriction in the provocation test and the degree of atherosclerotic stenosis in the baseline or follow-up CAG were quantitatively analyzed via QCA.
Definitions
An ischemic ECG change was defined as an ST segment elevation or depression of >0.1 mV or a new appearance of a negative U wave in at least 2 related ECG leads. A multi-vessel spasm was defined as a vasospasm in more than 2 major epicardial coronary arteries (vessel size: >2.5 mm). A coronary vasospasm that was simultaneously provoked in more than 2 consecutive segments of the major epicardial coronary artery was defined as a diffuse type of coronary vasospasm. The reduction and cessation of the medication were also defined as the introduction of a gap in the medication use and the non-use of medication, respectively. A high level of high-sensitivity C-reactive protein (hsCRP) was defined as the level ≥0.3 mg/dl. The cut-off point of 0.3 mg/dl was based on the American Heart Association and Centers for Disease Control and Prevention scientific statement suggesting that levels ≥0.3 mg/dl be considered high. 14,15
Follow up and End Points
All the participants received vasodilators that included CCBs and/or nitrates during the follow-up period. In the cases of recurrent angina, a follow-up angiography with or without a VSA provocation test was recommended, and PCI was also performed at the clinician's discretion if the angiography showed significant atherosclerotic stenosis. The end-points were composed of cardiac deaths and the development of significant atherosclerosis leading to PCI. Cardiac death was defined as sudden death (death that occurred unexpectedly without any apparent symptom or within 1 h of the onset of symptoms, or non-witnessed death in the absence of any other possible cause) or death associated with acute MI or severe heart failure. 5 Most of the patient follow-up data were obtained with the use of the Web-based registry. Additional information was obtained from medical records and by calling the patients directly or their family members. The clinical, laboratory, and angiographic values were also analyzed to determine the independent risk factors for each end-point.
Statistical Analysis
Continuous variables were expressed as mean ± standard deviation values, and categorical variables, as percentages. The Fisher's exact test was used for the categorical variables, and the t-test was used for the continuous variables. Multivariate logistic regression analysis was performed to identify the independent factors for each end-point. Univariate variables with a P<0.20 were entered into the multivariate logistic models. The odds ratio and the 95% confidence intervals were also calculated. Free-from-cardiac death or PCI survival rates were displayed with Kaplan-Meier curves. A value of P<0.05 was considered statistically significant. All the statistical analyses were performed using the SPSS statistical software, version 18.0 (Chicago, IL, USA). 
Results
Follow up
A total of 831 patients with VSA were registered from 8 institutions. Eighty-six of these patients were excluded because they did not fit the inclusion criteria of this study (n=19), lacked fully available medical information that included the end-points of this study (n=20), and were lost to follow up (n=47). Thus, the final analysis was performed in 745 patients (89.7%). The mean follow-up duration was 36.1±9.8 months.
Rate of PCI
Of all the 745 patients, a follow-up CAG was performed in 110 patients (14.8%) due to recurrent resting angina (n=87, 79.1%), angina on exertion (n=20, 18.2%), and ACS (n=3, 2.7%). Of these 110 patients, 15 patients showed the development of significant atherosclerosis, and they all underwent PCI (15/745, 2.01%, PCI rate). The mean duration from the diagnosis to PCI was 27.5±9.9 months. Six patients developed significant atherosclerosis in their coronary spasm-positive segments. Figure 1 shows the angiographic findings for 1 of the 6 patients. This patient, a 59-year-old male, had been diagnosed with VSA via a diffuse vasospasm in the proximal and distal segments of his RCA. After 29 months, a follow-up CAG was performed due to angina on exertion for 2 months, and it showed significant atherosclerotic stenosis in the proximal segment of the RCA that led to PCI (Figure 1) . The remaining 9 patients developed significant atherosclerosis in their coronary spasmnegative segment. Eight of the 15 patients who underwent PCI developed significant atherosclerosis in their segment with minimal atherosclerosis in the initial baseline CAG, and the remaining 7 patients had angiographically normal findings in their baseline CAG. All the patients who underwent PCI survived to the end of this study. The clinical, laboratory, and angiographic characteristics of the non-PCI and PCI groups are presented in Table 1 . Their angiographic characteristics did not significantly differ. In addition, in the 2 groups, the numbers of patients who stopped their medication and to whom statins and anti-platelet agents, including aspirin, were prescribed did not significantly differ. The number of males and the frequency of current smoking were higher in the PCI group, however, than in the non-PCI group (P<0.05). The PCI group also had a higher level of baseline hsCRP at the time of the initial provocation test than the non-PCI group. And also, the PCI group showed a higher number of patients with high levels of hsCRP (>0.3 mg/dl) than the non-PCI group (P<0.05, Table 1 ). The univariate analysis showed a P<0.20 for the numbers of male, diabetes, smoking, and high level of hsCRP. Among these variables, smoking and a high level of baseline hsCRP were revealed in the multivariate logistic regression analysis as independent risk factors for the development of significant atherosclerosis leading to PCI ( Table 2) .
Cardiac Mortality
Among the 745 patients who were included in this study, 19 died during the follow-up period (2.55%). Eleven patients died due to cardiac causes (1.48%, cardiac mortality rate). Of the patients who died from cardiac causes, 3 had acute fatal MI; 4 from severe heart failure; and 4 from sudden cardiac death. The mean duration from the VSA diagnosis to cardiac death was 10.6±4.3 months. The detailed characteristics of the 11 patients who died due to cardiac causes were demonstrated in Table 3 . Table 4 shows the baseline characteristics of the survivor and cardiac death groups (the 8 patients who died from noncardiac causes were excluded). The frequency of current smoking and the number of patients who stopped the medication during the follow-up period were significantly higher in the The survival rates free from cardiac death were 98.8%, 98.5%, and 98.5%, respectively, at 12, 24, and 36 months. PCI, percutaneous coronary intervention. Long-Term Prognosis of Korean VSA Patients cardiac death group than in the survivor group (P<0.05). There were also significantly more patients in the cardiac death group, in whom a multi-vessel spasm was provoked in the initial provocation test, than in the survivor group (P<0.05). A history of dyslipidemia was more frequent in the survivor group than in the cardiac death group (P<0.05, Table 4 ). The univariate analysis showed a P<0.20 for the number of males, current smoking, cessation of medication, multi-vessel spasm, and the diffuse type of spasm. In the multivariate logistic regression analysis, cessation of medication during the follow-up period was an independent risk factor for cardiac mortality in the VSA patients ( Table 2) .
Survival Curves
Kaplan-Meier analysis demonstrated that the survival rate free from PCI at 36 months was 98.1% and the survival rate free from cardiac death was 98.5% at 36 months. Most cardiac deaths occurred within 12 months, while PCI was performed in the relatively late periods of the follow up (Figure 2) . Survival rates free from cardiac death in patients who stopped medications and in patients who continued medications were significantly different (P<0.001). While the survival rate at 36 months was 99.7% in patients who continued medications, the survival rate in patients who stopped medication was 77.7% at 36 months (Figure 3) .
Discussion
This study showed an all-cause mortality rate of 2.55%, a cardiac mortality rate of 1.48%, and a PCI rate of 2.01% during the 36-month follow up of Korean patients with VSA.
Rate of PCI
This is the first study to present the rate of development of significant atherosclerosis leading to PCI in Asian patients with VSA. The close association between coronary spasm and atherosclerosis has been suggested. Reduced endothelial nitric oxide (NO) synthase-derived NO bioactivity from coronary endothelial dysfunction, a key pathogenesis of coronary spasm, is also a critical step in the development of atherosclerosis. 16 Yamagishi et al performed an intravascular ultrasound (IVUS) study and they indicated that atherosclerosis was present at the site of the focal vasospasm, even in the absence of angiographically significant stenosis. 9 More recently, Hong et al documented that the sites of vasospasms in VSA patients had the characteristics of atherosclerotic changes in the IVUS examination. 17 Moreover, in VSA patients who suddenly died, the autopsy findings showed focal thickening of the intima at the segment of the vasospasm. 18 These findings could indicate that coronary spasms are closely associated with coronary atherosclerosis.
In contrast, previous reports suggested that coronary vasospasm itself might contribute to the accelerated progression of atherosclerosis. Coronary spasms could induce the release of potent vasoconstrictors, and thus, provoke vascular injury that leads to the formation of neo-intimal hyperplasia. The reduction in the coronary blood flow and the increase in the platelet activation that leads to local thrombus formation in the spasmpositive coronary segments could also contribute to the progression of atherosclerosis. 9-12 In Japan, Nobuyoshi et al suggested that coronary spasm was an independent risk factor for MI occurrence. 12 In this study, however, only 2.01% of the patients (15/745) developed significant atherosclerosis during the 36-month follow-up. The causes of the lower-than-expected PCI rate in this study could be associated with several factors. First, all the patients received the intensive medical treatment that included vasodilators and statins during follow up. Particularly, statins were continuously prescribed in approximately 70% of patients (Table 1) , which could be very helpful in preventing the progression of atherosclerosis. 19 Second, a follow-up CAG was performed in a relatively low number of patients (14.8%). Because silent ischemia often occurs and the vasodilators could mask the patient's ischemic symptoms, 1 a follow-up CAG with or without a VSA provocation test should be more strongly recommended in future studies if clinically indicated. Finally, in this study, IVUS was not performed. Because conventional angiography might miss detecting intramural diseases, 9 the estimation of the progression or Figure 3 . Survival rates in patients who stopped medications and in patients who continued medications. The survival rates free from cardiac death at 12, 24, and 36 months were 82.8%, 77.7%, and 77.7%, respectively, in patients who stopped medications (red). In patients who continued medications (blue), the survival rates at 12, 24, and 36 months were 99.7%, 99.7%, and 99.7%, respectively. SHIN DI et al.
development of atherosclerosis in this study might not have been precise. Additionally, in this study, only a low number of patients developed significant atherosclerosis in their spasmpositive segments, which suggested that the development of significant atherosclerosis could not be related to spasm-positive segments. Furthermore, large-scale studies should be conducted to clarify the association between coronary spasm and progression of atherosclerosis.
This study showed that smoking and high levels of baseline hsCRP are independent factors of the development of significant atherosclerosis. Smoking has been regarded as an important risk factor of atherosclerotic coronary disease. 6 Additionally, it can lead to constant and severe endothelial damage, which is the initial manifestation of atherosclerosis. 6 The longterm survival rate of patients with VSA is usually favorable, as long as the patients avoid smoking. 1 Chronic low-grade inflammation plays an important role in the pathogenesis of coronary spasm. 20 Also, inflammation is an important factor in all phases of the atherosclerotic process. 16,21 Several largescale prospective studies have shown that the plasma level of hsCRP was a strong independent predictor of future cardiovascular events, which were consistent with our results. 20,22
Cardiac Mortality
The patients with VSA in this study had favorable outcomes with a low cardiac death rate (1.48%). This is compatible with the results of previous studies. Wang et al reported no cardiac deaths and only 2 patients with non-fatal MI among 38 VSA patients during the 25-month follow up. 23 Ito et al also reported survival rates of 98% and 94% at 5 and 10 years, respectively. 24 More recently, a European study resulted in no cardiac death and non-fatal MI during a 3-year follow up. 6 The slightly higher incidence of cardiac deaths in this study, compared to some previous studies, 6,16 might have been due to the different inclusion criteria. Because in this study, patients with severe heart failure were not excluded, a slightly higher incidence of cardiac deaths was likely. Actually, out of 11 patients who died from cardiac causes in this study, 4 (36.4%) died due to severe heart failure. In contrast, some previous studies reported a higher incidence of MI and cardiac deaths in VSA patients. 25, 26 Hannebicque et al showed that 10.6% of patients with VSA had a MI during a 55-month follow up. 25 However, all these patients with MI showed an obstructive coronary artery disease on the baseline CAG. In this study, the patients who had significant fixed stenosis in their baseline CAG were excluded, which explains the higher incidence of adverse cardiac events in the previous report than in this study.
In this study, most cardiac deaths occurred in the early periods of the follow up. Previous reports suggested that the prognosis of VSA patients could be favorable if early complications can be overcome. 1, 27 Kishida et al reported that most cardiac events occurred within 1 month from the onset of VSA. 27 Moreover, Bory et al reported that the rate of MI in patients with VSA during an 89-month follow up was 6.5%, and that half of the MI cases occurred within the first year of follow up. 7 These are consistent with the results of this study, which emphasized the importance of intensive early-phase treatment of patients with VSA.
Many predictors of the long-term prognosis of VSA patients, such as the number of coronary arteries with significant fixed stenosis, maintenance of CCBs, smoking, and multi-vessel spasm, were suggested in previous studies. 1,28, 29 In particular, the multi-vessel spasm has been regarded as one of the highest risk forms of coronary spasm. 16 In this study, however, only one-third of the patients showed multi-vessel spasm. It was relatively lower than the incidence in previous reports. 5,25,26 Cessation of medication was only an independent risk factor for cardiac death in Korean VSA patients in our analysis. After withdrawal from the medication, which included CCBs, silent myocardial ischemia with fatal arrhythmias and a rebound phenomenon of the coronary spasm could occur. 5,26, 28 Moreover, a recent study in Japan indicated that the incidence of cardiac deaths significantly increased in patients whose medications were discontinued. 5 These findings suggest that the medications should not be withdrawn carelessly in VSA patients. It is still indefinite how long the administration of the medications, including of CCBs, should be continued. 1 Further studies should be performed to establish the standard guidelines for the medical treatment of VSA patients.
Study Limitations
This study had several limitations. First, it was a retrospective study in which data-sets of the registry were used, and thus, the association demonstrated in this study was not necessarily causal. In addition, several baseline characteristics were different from those in previous reports, although the precise reasons were not clear. In our study, female patients accounted for 45% of total subjects. It was a high percentage, compared with other reports. And the incidence of multi-vessel spasm was relatively lower than that in other previous studies. Second, only a small number of patients with VSA were included in the final analysis. To address these issues, a longterm large-scale study is planned to determine the prognosis of Korean patients with VSA. Third, there is no sufficient information about the prescription of therapeutic medications including CCBs. However, the prescription pattern of CCBs was relatively similar, most likely due to the same affiliation of the participating institutions. Diltiazem, a non-dihydropyridine CCB, was the most frequently prescribed for the patients in our registry, which was the physician's preference and the limited availability of prescription drugs in our medical centers. Finally, IVUS was not performed and the degrees of atherosclerotic stenosis in the baseline and follow-up CAGs were quantitatively analyzed with only QCA. Thus, the estimation of the atherosclerotic change could not be precise and the occult atherosclerosis in the baseline CAG might have been missed. Despite these limitations, however, this study could be helpful in understanding the long-term prognosis of Korean patients with VSA.
Conclusion
In conclusion, the rates of development of significant atherosclerosis that leads to PCI and cardiac mortality in Korean patients with VSA were very low, which indicate a favorable outcome. However, cessation of medication, smoking, and high levels of baseline hsCRP were the independent risk factors for unfavorable outcomes.
